Loading...
Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
BACKGROUND: Metastatic pancreatic ductal adenocarcinoma (mPDAC) bears a dismal prognosis due to the limited activity of systemic chemotherapy. In our platform for precision medicine, we aim to offer molecular-guided treatments to patients without further standard therapy options. METHODS: In this si...
Na minha lista:
| Udgivet i: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357054/ https://ncbi.nlm.nih.gov/pubmed/32699558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920938611 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|